Business Continuity Management in the Biologic Industry Supply Chain: an Industry Best Practice Approach

Both before and throughout the recent COVID pandemic, preparedness to ensure business continuity in the event of supply disruption has been paramount to ensure the continued availability of patient therapies and uninterrupted business operations.

The BioPhorum ‘Best Practice Guide to Business Continuity Management in the Biologic Supply Chain’ is based on ongoing industry collaboration with subject matter experts and provides consensus recommendations to enhance the resilience of the biologics industry. It provides a framework based on internationally recognized standards. By systematically implementing these principles, which can be adapted to the scale and breadth of any individual company, companies can improve their business continuity management systems, supporting industry growth and meeting regulatory requirements.

This presentation shares how the guide promotes a consistent approach throughout the supply chain, benefiting patients, companies, and the industry as a whole, and details how to use the associated questionnaire and evaluation tool. Companies supporting the biologics supply chain are strongly encouraged to review existing practices alongside the proposed recommendations, in order to ensure effective management of disruptions, improve communication within the supply chain, and ultimately benefit patients, companies, and the industry as a whole.